Membranoproliferative glomerulonephritis
Factor I is required for the development of membranoproliferative glomerulonephritis in factor H–deficient mice
12
A case report of recurrent membranoproliferative glomerulonephritis after kidney transplantation due to ventriculoatrial shunt infection
6
Development of membranoproliferative glomerulonephritis-like glomerulopathy in a patient with neutrophilia resulting from endogenous granulocyte-colony stimulating factor overproduction: a case report
5
Membranoproliferative glomerulonephritis with predominant IgG2 and IgG3 deposition in a patient with IgG4-related disease
7
Membranoproliferative glomerulonephritis complicating Waldenström’s macroglobulinemia
5
Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency
9
Membranoproliferative glomerulonephritis presenting as arthropathy and cardiac valvulopathy in hypocomplementemic urticarial vasculitis: a case report
5
Membranoproliferative glomerulonephritis recurrence after kidney transplantation: using the new classification
9
Fundus changes in type III membranoproliferative glomerulonephritis: a case report
6
C4 nephritic factor in patients with immune-complex-mediated membranoproliferative glomerulonephritis and C3-glomerulopathy
14
Long-term outcomes of patients with end-stage kidney disease due to membranoproliferative glomerulonephritis: an ANZDATA registry study
9
Membranoproliferative glomerulonephritis with deposition of monoclonal IgG evolved from polyclonal IgG: a case report with two consecutive renal biopsies
7
Disseminated strongyloidiasis in a patient with membranoproliferative glomerulonephritis-case report.
5
Membranoproliferative Glomerulonephritis and α1-Antitrypsin Deficiency in Children
7
Membranoproliferative Glomerulonephritis in Childhood Cirrhosis Associated With Alpha1-Antitrypsin Deficiency
9
The Value of Immunofluorescence in Renal Diseases with Special Reference to Periodic Acid Schiff and Jone’s Methanamine Silver Stain
171
Properdin and C3 Proactivator: Alternate Pathway Components in Human Glomerulonephritis
12
Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis
13
CTGF in kidney fibrosis and glomerulonephritis
8
Quantification of cancer risk in glomerulonephritis
16